BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 28, 2003
View Archived Issues
EPIX In $28M Deal To Develop Contrast Agents With Schering
EPIX Medical Inc. is returning to a familiar partner, Schering AG, to develop contrast agents for use in MRI in a deal that could garner up to $28 million in near-term money for EPIX.(BioWorld Today)
Read More
Medivir, GSK Agree To EUR86M Deal For Phase I HIV Candidate
Read More
Peninsula In-Licenses Late-Stage Antibiotic From Japanese Firm
Read More
Vitex Offering Brings In $14.4M For Blood Purifying Technology
Read More
Other News To Note
Read More